PreprintAll rights reservedmedRxiv
Hormone Replacement Therapy and Disability Progression in Women with Multiple Sclerosis
- 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Related
- A Blood-Based Synaptic Biomarker in Neuronally-Enriched Extracellular Vesicles Predicts Disability Progression in Progressive Multiple Sclerosis
- Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study
- Apathy-depression overlap: unmasking hidden disability profiles in multiple sclerosis
- Anti‐CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis
- Rest-activity and circadian rhythm parameters relate to cognition and disability outcomes in multiple sclerosis
BibTeX
@misc{copeland2026hormone,
title = {{Hormone Replacement Therapy and Disability Progression in Women with Multiple Sclerosis}},
author = {T. P. Copeland and K. A. McKay and A. Pedersen and R. Handal-Orefice and K. Fink},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.21.26366096},
url = {https://www.medrxiv.org/content/10.64898/2026.10.21.26366096v1},
}
RIS
TY - UNPB
TI - Hormone Replacement Therapy and Disability Progression in Women with Multiple Sclerosis
AU - T. P. Copeland
AU - K. A. McKay
AU - A. Pedersen
AU - R. Handal-Orefice
AU - K. Fink
PY - 2026
DA - 2026/10/21
PB - medRxiv
DO - 10.64898/2026.10.21.26366096
UR - https://www.medrxiv.org/content/10.64898/2026.10.21.26366096v1
ER -